Zacks.com on MSN1d
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should KnowIn the most recent trading session, Eli Lilly (LLY) closed at $822.27, indicating a -0.22% shift from the previous trading day.
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program ...
As we continue to advance our Axiomer ADAR-mediated RNA editing platform and pipeline, ProQR is entering a pivotal phase of growth and ...
Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expect ...
MariTide’s opportunity in diabetes should not be ignored. In addition to reducing weight by 17%, it reduced HbA1c up to 2.2% ...
24/7 Wall St. on MSN3d
2 Stocks That Could Split Very SoonStock splits tend to create a lot of buzz in the market, especially when some of the most prominent companies announce a ...
AN ALZHEIMER’S drug hailed as a ‘miracle’ medicine for dementia may cause life-threatening brain bleeds in a third of ...
Novo Nordisk shares declined on Monday after the company reported that its next-generation weight-loss drug, CagriSema, ...
Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...
The Vanguard Mega Cap ETF is outperforming the S&P 500 but lagging peers like XLG and OEF. Read more on the analysis of MGC ...
Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...
Eli Lilly (LLY) stock dropped by 0.22%, underperforming the S&P 500’s 0.49% gain. Over the past month, the stock has fallen 4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback